NL
VIR icon

NVWM LLC’s Vir Biotechnology VIR Stock Holding History

NVWM LLC’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$896 Buy
+100
New +$797 ﹤0.01% 589
2023
Q3 		– Sell
-29,847
Closed -$732K – 482
2023
Q2 		$732K Buy
29,847
+6,050
+25% +$152K 0.24% 134
2023
Q1 		$554K Buy
+23,797
New +$609K 0.19% 153

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

NVWM LLC's VIR Position: Q1 2026 in Review

NVWM LLC opened a new position in Vir Biotechnology (VIR) in Q1 2026: 100 shares worth $896. The stake represents ﹤0.01% of the portfolio and ranks #589 among its holdings. This is a return to the name: NVWM LLC previously reported a position in VIR as recently as Q2 2023.

NVWM LLC first reported a position in VIR in Q1 2023 and has held it in 3 quarters since. The position peaked at $732K in Q2 2023. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • NVWM LLC held 100 shares of Vir Biotechnology worth $896 as of Q1 2026.
  • Vir Biotechnology was a new NVWM LLC position in Q1 2026.
  • Vir Biotechnology made up ﹤0.01% of NVWM LLC's portfolio in Q1 2026, its #589 holding.
  • NVWM LLC first reported a position in Vir Biotechnology in Q1 2023 and has held it in 3 quarters since.
  • NVWM LLC's Vir Biotechnology position peaked at $732K in Q2 2023.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on NVWM LLC's 13F filing for Q1 2026, filed 27 Apr 2026.